Want to see TSE:ENBI.X full AI Analyst Report?
Entheon Biomedical (ENBI.X) Stock Forecast & Price Target
ENBI.X Analyst Ratings
There are no analyst ratings in the last 3 months.
ENBI.X Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | CAD 0.05 | hold | -3.64%Downside | Upgraded | 11/02/26 | ||
| Google Biotechnology | TipRanks - Google | CAD 0.05 | sell | -5.45%Downside | Reiterated | 11/02/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | CAD 0.05 | hold | -3.64%Downside | Upgraded | 11/02/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | CAD 0.05 | hold | -3.64%Downside | Reiterated | 11/02/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | CAD 0.06 | hold | 0.00%Upside | Upgraded | 11/02/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | CAD 0.05 | hold | -1.82%Downside | Reiterated | 11/02/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 11/02/26 | CAD 0.05 | hold | -3.64%Downside | Upgraded | TipRanks - PerPlexity | ||
| Google Biotechnology | 11/02/26 | CAD 0.05 | sell | -5.45%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 11/02/26 | CAD 0.05 | hold | -3.64%Downside | Upgraded | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 11/02/26 | CAD 0.05 | hold | -3.64%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 11/02/26 | CAD 0.06 | hold | 0.00%Upside | Upgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 11/02/26 | CAD 0.05 | hold | -1.82%Downside | Reiterated | TipRanks - xAI |
Best Analysts Covering Entheon Biomedical
No data currently available
Copying Google Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +51.80% per trade.
Copying Google Biotechnology's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.80% per trade.
ENBI.X Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ENBI.X has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENBI.X average Analyst price target in the past 3 months is ―.
ENBI.X Financial Forecast
ENBI.X Sales Forecast
Next quarter’s sales forecast for ENBI.X is CAD 0 with a range of ― to ―. The previous quarter’s sales results were CAD 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
